No popular authors found.
Ads by Google:

Categories

No categories found.


Get Celiac.com's E-Newsletter





Ads by Google:


Follow / Share


  FOLLOW US:
Twitter Facebook Google Plus Pinterest RSS Podcast Email  Get Email Alerts
SHARE:

Popular Articles

No popular articles found.
Celiac.com Sponsors:

Glutenase ALV003 Protects Celiacs Against Gut Damage from Gluten

Celiac.com 06/02/2014 - Despite following a gluten-free diet, many people with celiac disease continue to have symptoms, and to suffer from ongoing small intestinal inflammation. Can a drug be created to alleviate such symptoms and inflammation, and protect celiacs on a gluten-free diet against small amounts of gluten contamination?

Photo: Wikimedia Commons--amitchel125San Carlos California-based Alvine Pharmaceuticals is conducting a phase 2 trial to determine whether their drug, ALV003, an orally administered mixture of 2 recombinant gluten-specific proteases can protect celiac disease patients from gluten-induced mucosal damage. For this trial, Alvine is working with researchers Marja-Leena Lähdeaho, Katri Kaukinen, Kaija Laurila, Pekka Vuotikka, Olli-Pekka Koivurova, Tiina Kärjä-Lahdensuu, Annette Marcantonio, Daniel C. Adelman, and Markku Mäki.

They are affiliated with the School of Medicine and Tampere University Hospital at the University of Tampere; the Department of Gastroenterology and Alimentary Tract Surgery at Tampere University Hospital and School of Medicine at the University of Tampere, and FinnMedi Oy in Tampere, Finland; the Department of Medicine at Seinäjoki Central Hospital in Seinäjoki, Finland; Liikuntaklinikka, Oulu Diakonissalaitos; and Terveys, Oulu Diakonissalaitos, Oulu, Finland.

For their Phase 2 trial, the research team first established two grams of gluten per day as the optimal challenge dose for their 6-week gluten study. They then randomly assigned 20 adults with biopsy-proven celiac disease to receive ALV003, and twenty-one to receive a placebo. Both groups also received 2 grams of gluten each day. The team conducted duodenal biopsies at baseline, and after gluten challenge, focusing on the ratio of villus height to crypt depth and densities of intraepithelial lymphocytes.

Ads by Google:

A total of seven patients dropped out due to adverse reactions. Four were receiving ALV003, and three were receiving the placebo. Sixteen patients given ALV003 and 18 given placebo were eligible for efficacy evaluation. Biopsies from subjects in the placebo group showed evidence of mucosal injury after gluten challenge, with average villus height to crypt depth ratio changed from 2.8 before challenge to 2.0 afterward. (P = .0007; density of CD3þ intraepithelial lymphocytes changed from 61 to 91 cells/mm after challenge; P = .0003).

However, the team saw no significant mucosal deterioration in biopsies from the ALV003 group. The two groups showed no significant differences in symptoms, though they did show substantial differences in morphologic changes, and CD3þ intraepithelial lymphocyte counts differed significantly from baseline to week 6 (P = .0133 and P = .0123, respectively). This small, but important, step means that ALV003 did provide significant protection against gluten-induced gut damage for people with celiac disease on an otherwise gluten-free diet, which means that Alvine can continue to the next phases in the development process.

If successful, glutenase ALV003 will be the first drug to protect people with celiac disease against gut damage from small amounts of gluten.

Source:

  • Clinicaltrial.gov, Numbers: NCT00959114 and NCT0125569

Celiac.com welcomes your comments below (registration is NOT required).












Related Articles



1 Response:

 
Lee
Rating: ratingfullratingfullratingfullratingfullratingfull Unrated
said this on
10 Jun 2014 5:01:57 PM PDT
Interesting article. I have celiac disease. Hoping for more help than a GF diet.




Rate this article and leave a comment:
Rating: * Poor Excellent
Your Name *: Email (private) *:




In Celiac.com's Forum Now:


I will just stick with christopherbean company, the fact the main sales rep I talk to has celiac in the family means a lot, she said they use it all the time. I tested some of the iffiest flavored version grounds for gluten all negative. NOT had any issues drinking all kinds of coffee from their ...

I agree!

Ch88 yes im glad i had the blood test but it was found by accident so bit of a shock when i found out. God knows how long i had it but i always remember as a child suffering from stomach pain alot but back in the eighties it was unheard off! But if you or any other membets can offer advice on w...

Most of the articles you presented were blogs. They focused in one article pushed by the American Chemical Society. The research looked at ground coffee in Brazil ONLY. https://www.acs.org/content/acs/en/pressroom/newsreleases/2014/august/keeping-filler-ingredients-out-of-your-cup-of-cof...

Okay, a positive on thyroid antibodies, but what about the rest of the thyroid panel? That tells more of the story. Is rest of the thyroid panel all in the normal ranges? Is that why you were recommended to take a supplement instead of actual thyroid hormone replacement? Many doctors try a...